[RENAPE network: Towards more equitable access to care and expertise for patients with rare peritoneal cancers].
Fiche publication
Date publication
juin 2024
Journal
Annales de pathologie
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BIBEAU Frédéric
Tous les auteurs :
Villeneuve L, Odin C, Bonnefoy I, Pichon P, Valmary-Degano S, Bibeau F, ,
Lien Pubmed
Résumé
Since its creation in 2010, the progressive structuration of the RENAPE network (Réseau national de prise en charge des tumeurs rares du péritoine) supported by the "Institut national du cancer" and the "Direction générale de l'offre de soins", allowed the optimization of the healthcare system involved in the management of the rare cancers of the peritoneum. In this setting, the RENA-PATH group has also been reinforced, notably by its recognized diagnostic expertise in pathology and its interface with the MESOPATH group. Moreover RENAPE and RENA-PATH led to guidelines diffusion through the integration, in 2019, to the ``Thesaurus National de Cancérologie Digestive'' (TNCD) and to post-university medical education programs. The aim of this article is to highlight the missions of the RENAPE and RENA-PATH, notably the equity in terms of expertise, access to the networks and their improvement in the management of peritoneal diseases.
Mots clés
Cancer rare, Network, Peritoneum, Péritoine, RENA-PATH, RENAPE, Rare cancer, Réseau
Référence
Ann Pathol. 2024 06 4;: